Get the Stockscreener App
26.02
11.63%
2.71
Anbio Biotechnology stock is traded at $26.02, with a volume of 21,226.
It is up +11.63% in the last 24 hours and down -7.30% over the past month.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
See More
Previous Close:
$23.31
Open:
$23.61
24h Volume:
21,226
Relative Volume:
0.37
Market Cap:
$1.14B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+52.16%
1M Performance:
-7.30%
6M Performance:
+270.13%
1Y Performance:
+0.00%
1-Day Range:
$23.24
$27.69
1-Week Range:
$16.40
$27.69
52-Week Range:
$5.60
$55.65
Anbio Biotechnology Stock (NNNN) Company Profile
Name
Anbio Biotechnology
Sector
Industry
Phone
-
Address
-
Compare NNNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
26.02 | 1.02B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Anbio Biotechnology Stock (NNNN) Latest News
Anbio Biotechnology Appoints New Auditor - TipRanks
Anbio Biotechnology (N3B.F) latest press releases and corporate news - Yahoo Finance UK
Anbio Biotechnology trading halted, volatility trading pause - MSN
Medtech test developer Anbio files for $9M US IPO - MSN
Why Anbio Biotechnology Class A Stocks Are Tumbling - TipRanks
Anbio Biotechnology trading resumes - MSN
Anbio Biotechnology Shares on a Wild Ride - TipRanks
Anbio Biotechnology falls -19.5% - MSN
Why Anbio Biotechnology Stock is Tumbling - TipRanks
Anbio Biotechnology (NNNN) Stock Forecast & Price Targets: Today, Tomorrow, Next Week - Traders Union
Anbio Biotechnology (NNNN) Stock Price Today | Live Chart & News - Traders Union
Anbio Biotechnology (NNNN) Stock Price Prediction for 2025, 2026, 2030-2040 - Traders Union
Anbio Biotechnology falls -5.5% - MSN
Anbio Biotechnology falls -26.6% - MSN
Why Anbio Biotechnology’s Stock is Tumbling - TipRanks
Anbio Biotechnology (N3B.F) Stock Price, News, Quote & History - Yahoo
Anbio Biotechnology’s Hype And Hard Approvals Suggest A Stretched Valuation (NNNN) - Seeking Alpha
Anbio Biotechnology (N3B.F) Latest Press Releases & Corporate News - Yahoo
Anbio Biotechnology (NNNN) Stock Report: Navigating a Tumultuous Year Amidst a 52-Week Price Fluctuation - DirectorsTalk Interviews
Anbio Biotechnology prices $8M IPO at $5 per share - MSN
Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025 - digitalmore.co
Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400% - inkl
Anbio Biotechnology rises 40.5% - MSN
Anbio Biotechnology Class A Shares Take a Tumble - TipRanks
White Mountains Insurance, Rumble, Mesoblast And Other Big Stocks Moving Higher On Friday - Benzinga
Dow Jumps Over 200 Points; ISM Services PMI Falls In September - inkl
S&P 500 Futures Rise in Premarket Trading; Anbio Biotechnology, Rigetti Computing Lead - Barron's
Anbio Biotechnology Stock Tumbles Amid Volatility - TipRanks
Liverpool Ferry Port Faces Repairs Due to Berth Damage - Berawang News
Jake LaRavia Talks Lakers Role After JJ Redick’s Media Day Insights - Berawang News
Manchester United legend wants Arsenal to win the league – Daily Cannon - Berawang News
Will RSVR stock go up soonJuly 2025 Gainers & Capital Protection Trading Alerts - newser.com
What does recent volatility data suggest for GAN Limited2025 Market Outlook & High Conviction Buy Zone Alerts - newser.com
Ottobock plans 2025 IPO on Frankfurt exchange - BioWorld MedTech
What the charts say about Deswell Industries Inc. todayTrade Volume Summary & Fast Moving Market Watchlists - Newser
Non-operating income, total of Anbio Biotechnology Class A – LSX:A40J71 - TradingView
Visual trend scoring systems applied to Puma Biotechnology Inc.Trade Volume Summary & Fast Exit Strategy with Risk Control - Newser
Is AMZE showing signs of accumulationEarnings Overview Report & Real-Time Buy Zone Alerts - Newser
Sentiment Turns Positive on ASGN Incorporated — Reversal AheadWeekly Stock Report & Daily Momentum Trading Reports - beatles.ru
Is Climb Bio Inc. showing signs of accumulation2025 Trade Ideas & High Conviction Investment Ideas - Newser
Are Bears Losing Grip on BLFS? getLinesFromResByArray error: size == 0 - 더경남뉴스
Analyzing Share Issuance and Voting Rights Dynamics in Growth-Stage Biotechs: Navigating Governance and Dilution Risks - AInvest
What earnings revisions data tells us about iBio Inc.2025 Big Picture & Real-Time Chart Breakout Alerts - Newser
LKY(linkey) Project ReviewTrade Exit Summary & Safe Entry Zone Identification - Newser
Is ACCESS Newswire Inc. forming a bottoming base2025 Year in Review & Expert Verified Movement Alerts - Newser
Real time breakdown of Graham Holdings Company stock performance2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - Newser
Is ZVIA stock poised for growthDollar Strength & Free High Accuracy Swing Entry Alerts - Newser
Technical signs of recovery in Fortive Corporation2025 Big Picture & Technical Entry and Exit Alerts - Newser
How High Can FHE(mind network) Go2025 EndofYear Setup & Safe Entry Zone Tips - Newser
Will Grayscale Ethereum Trust outperform the marketJuly 2025 Catalysts & Weekly Breakout Stock Alerts - Newser
Live market analysis of HJJ CLMarket Movement Recap & Verified Technical Signals - Newser
Anbio Biotechnology Stock (NNNN) Financials Data
There is no financial data for Anbio Biotechnology (NNNN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.23%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):